Skip to main content
Terug
Watch Compare

ENvue Medical, Inc.

Datakwaliteit: 100%
FEED
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 1,75
▼ € 0,09 (-4,89%)
Marktkapitalisatie: 1,90 M
Prijs
€ 1,75
Marktkapitalisatie
1,90 M
Dagbereik
€ 1,68 — € 1,81
52-Weeksbereik
€ 0,99 — € 88,20
Volume
133.428
Openen € 1,80
50D / 200D Gem.
€ 2,22
21,26% below
50D / 200D Gem.
€ 4,98
64,87% below

Quick Summary

Belangrijkste Punten

Revenue grew 42,35% annually over 5 years — strong growth
Negative free cash flow of -7,28 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 30,30%
Capital efficient — spends only 1,38% of revenue on capex

Groei

Revenue Growth (5Y)
42,35%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)12,05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-16,31%
Boven sectorgemiddelde (-53,47%)
ROIC-17,02%
Net Margin-251,92%
Op. Margin-351,77%

Veiligheid

Debt / Equity
N/A
Current Ratio0,86
Interest Coverage-33,26

Waardering

PE (TTM)
-0,28
Boven sectorgemiddelde (-1,47)
P/B Ratio0,04
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -0,3 -1,5
P/B 0,0 1,6
ROE % -16,3 -53,5
Net Margin % -251,9 -41,5
Rev Growth 5Y % 42,4 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 12,05% Revenue Growth (3Y) 84,43%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 42,35% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2,69 M Net Income (TTM) -6,76 M
ROE -16,31% ROA -12,78%
Gross Margin 30,02% Operating Margin -351,77%
Net Margin -251,92% Free Cash Flow (TTM) -7,28 M
ROIC -17,02% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,86
Interest Coverage -33,26 Asset Turnover 0,05
Working Capital -1,63 M Tangible Book Value -1,44 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,28 Forward P/E N/A
P/B Ratio 0,04 P/S Ratio 0,71
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -382,34%
Market Cap 1,90 M Enterprise Value -5,05 M
Per Share
EPS (Diluted TTM) -19,58 Revenue / Share 2,47
FCF / Share -6,69 OCF / Share -6,66
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1,38% FCF Conversion 107,64%
SBC-Adj. FCF -7,50 M Growth Momentum -30,30

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 2,56 M 2,28 M 752.000,0 1,70 M 623.000,0
Net Income -3,71 M -3,71 M -5,45 M -14,28 M -4,33 M
EPS (Diluted) -13,73 -2,12 — — —
Gross Profit 1,51 M 1,54 M 167.000,0 770.000,0 214.000,0
Operating Income -3,58 M -3,44 M -5,01 M -5,68 M -4,72 M
EBITDA — — — — —
R&D Expenses 909.000,0 185.000,0 283.000,0 293.000,0 171.000,0
SG&A Expenses — — — — —
D&A 1.000,0 1.000,0 1.000,0 2.000,0 2.000,0
Interest Expense 135.000,0 135.000,0 347.000,0 147.000,0 147.000,0
Income Tax 19.000,0 29.000,0 35.000,0 32.000,0 15.000,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 3,63 M 6,67 M 5,88 M 8,62 M 8,23 M
Total Liabilities 3,00 M 2,69 M 2,65 M 2,31 M 5,84 M
Shareholders' Equity 627.000,0 3,99 M 3,23 M 6,31 M 2,39 M
Total Debt — — — — —
Cash & Equivalents — — — 7,74 M 7,14 M
Current Assets 3,33 M 6,49 M 5,61 M 8,34 M 7,97 M
Current Liabilities 2,72 M 2,45 M 2,32 M 1,90 M 2,90 M